1. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas;Rosenberg;Cancer Treatment Reports,1977
2. Harrington DP, Klatt MM et al;Shipp;Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Int Med,1986
3. Prognostic model for prognosis in advanced diffuse histiocytic lymphoma;Danieu;Cancer Res,1986
4. Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data;Velasquez;Blood,1989
5. Intensive chemotherapy in aggressive lymphomas;Coiffier;Updated results of LNH-80 protocol and prognostic factors affecting response and survival. Blood,1987